Preclinical evaluations of PF-00868554, a potent non-nucleoside inhibitor of the hepatitis C virus RNA polymerase

被引：0

作者：

Shi, Stephanie ^{[1
]}

Herlihy, Koleen ^{[1
]}

Irvine, Rebecca ^{[1
]}

Binford, Susan ^{[1
]}

Lewis, Cristina ^{[1
]}

Nonomiya, Jim ^{[1
]}

Patick, Amy ^{[1
]}

机构：

[1] Pfizer, San Diego, CA USA

来源：

HEPATOLOGY | 2007年 / 46卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1394

引用

页码：858A / 859A

页数：2

共 50 条

[21] PRECLINICAL CHARACTERIZATION OF ABT-072: A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
Wagner, R.
Maring, C.
Donner, P.
Randolph, J.
Krueger, A.
Kati, W.
Koev, G.
Liu, Y.
Beno, D.
Shen, J.
Gao, Y.
Lau, Y. Y.
Fischer, J.
Vaidyanathan, S.
Beyer, J.
Lim, B. H.
Mondal, R.
Rockway, T.
Pratt, J.
Liu, D.
Tufano, M.
Molla, A.
JOURNAL OF HEPATOLOGY, 2009, 50 : S352 - S352
[22] Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay
Nakajima, Shogo
Watashi, Koichi
Fukano, Kento
Tsukuda, Senko
Wakae, Kousho
Aizaki, Hideki
Muramatsu, Masamichi
Wakita, Takaji
Toyoda, Tetsuya
JOURNAL OF GASTROENTEROLOGY, 2020, 55 (04) : 441 - 452
[23] Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-Nucleoside Analogue Inhibitor
Mallalieu, Navita L.
Rahimy, Mohamad H.
Crowley, Constance A.
Appleman, James R.
Smith, Patrick F.
Freddo, James L.
CLINICAL THERAPEUTICS, 2014, 36 (12) : 2047 - +
[24] Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay
Shogo Nakajima
Koichi Watashi
Kento Fukano
Senko Tsukuda
Kousho Wakae
Hideki Aizaki
Masamichi Muramatsu
Takaji Wakita
Tetsuya Toyoda
Journal of Gastroenterology, 2020, 55 : 441 - 452
[25] Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase
Rigat, Karen L.
Lu, Hao
Wang, Ying-Kai
Argyrou, Argyrides
Fanslau, Caroline
Beno, Brett
Wang, Yi
Marcinkeviciene, Jovita
Ding, Min
Gentles, Robert G.
Gao, Min
Abell, Lynn M.
Roberts, Susan B.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) : 33456 - 33468
[26] Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase
Cummings, Maxwell D.
Lin, Tse-I
Hu, Lili
Tahri, Abdellah
McGowan, David
Amssoms, Katie
Last, Stefaan
Devogelaere, Benoit
Rouan, Marie-Claude
Vijgen, Leen
Berke, Jan Martin
Dehertogh, Pascale
Fransen, Els
Cleiren, Erna
van der Helm, Liesbet
Fanning, Gregory
Nyanguile, Origene
Simmen, Kenny
Van Remoortere, Pieter
Raboisson, Pierre
Vendeville, Sandrine
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1880 - 1892
[27] JTK-853, a Novel Non-Nucleoside Hepatitis C Virus Polymerase Inhibitor, Demonstrates a High Genetic Barrier to Resistance in vitro
Ando, Izuru
Ogura, Naoki
Toyonaga, Yukiyo
Hirahara, Kunihiro
Shibata, Tsutomu
Noguchi, Toru
INTERVIROLOGY, 2013, 56 (05) : 302 - 309
[28] Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective
Choong, Yee Siew
Lim, Theam Soon
Liu, Hanyun
Jiang, Rubin
Cai, Zimu
Ge, Yuan
LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (05) : 429 - 435
[29] Novel 4-Thiazolidinones as Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase
Cakir, Gizem
Kucukguzel, Ilkay
Guhamazumder, Rupa
Tatar, Esra
Manvar, Dinesh
Basu, Amartya
Patel, Bhargav A.
Zia, Javairia
Talele, Tanaji T.
Kaushik-Basu, Neerja
ARCHIV DER PHARMAZIE, 2015, 348 (01) : 10 - 22
[30] Susceptibility of different genotypes of hepatitis C virus to inhibition by nucleoside and non-nucleoside inhibitors
Carroll, S
Bailey, C
Bosserman, M
Burlein, C
Simcoe, A
Fay, J
Ludmerer, S
Graham, D
LaFemina, R
Flores, O
Hazuda, D
Altamura, S
Migliaccio, G
Tomei, L
De Francesco, R
Summa, V
Olsen, D
ANTIVIRAL RESEARCH, 2004, 62 (02) : A83 - A83

← 1 2 3 4 5 →